EG23417A - Process for the preparation 7 a-methylsteroids. - Google Patents

Process for the preparation 7 a-methylsteroids.

Info

Publication number
EG23417A
EG23417A EG2003010051A EG2003010051A EG23417A EG 23417 A EG23417 A EG 23417A EG 2003010051 A EG2003010051 A EG 2003010051A EG 2003010051 A EG2003010051 A EG 2003010051A EG 23417 A EG23417 A EG 23417A
Authority
EG
Egypt
Prior art keywords
methylsteroids
preparation
Prior art date
Application number
EG2003010051A
Inventor
Stoelwinder
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Application granted granted Critical
Publication of EG23417A publication Critical patent/EG23417A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C07J1/0085—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being a saturated hydrocarbon group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0081—Substituted in position 17 alfa and 17 beta
    • C07J1/0088—Substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0096—Alkynyl derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0007—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
    • C07J5/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
EG2003010051A 2002-01-21 2003-01-19 Process for the preparation 7 a-methylsteroids. EG23417A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02075230 2002-01-21
PCT/EP2003/000339 WO2003059931A1 (en) 2002-01-21 2003-01-14 PROCESS FOR THE PREPARATION OF 7α-METHYLSTEROIDS

Publications (1)

Publication Number Publication Date
EG23417A true EG23417A (en) 2005-06-28

Family

ID=8185555

Family Applications (1)

Application Number Title Priority Date Filing Date
EG2003010051A EG23417A (en) 2002-01-21 2003-01-19 Process for the preparation 7 a-methylsteroids.

Country Status (28)

Country Link
US (2) US20050090476A1 (en)
EP (1) EP1470151B1 (en)
JP (1) JP5250174B2 (en)
KR (1) KR100937179B1 (en)
CN (1) CN100372864C (en)
AR (1) AR038165A1 (en)
AT (1) ATE453659T1 (en)
AU (1) AU2003205604B8 (en)
BR (1) BRPI0306736B8 (en)
CA (1) CA2472379C (en)
DE (1) DE60330749D1 (en)
EC (1) ECSP045180A (en)
EG (1) EG23417A (en)
ES (1) ES2336439T3 (en)
HR (1) HRP20040634B1 (en)
IL (2) IL162770A0 (en)
IS (1) IS2740B (en)
MX (1) MXPA04007049A (en)
NO (1) NO327095B1 (en)
NZ (1) NZ533970A (en)
PE (1) PE20030926A1 (en)
PL (1) PL208163B1 (en)
RO (1) RO122913B1 (en)
RS (1) RS51490B (en)
RU (1) RU2305105C2 (en)
TW (1) TWI322813B (en)
WO (1) WO2003059931A1 (en)
ZA (1) ZA200405257B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10213371C1 (en) * 2002-03-21 2003-12-24 Schering Ag Process for the preparation of 7alpha methyl steroids
GB0304927D0 (en) * 2003-03-04 2003-04-09 Resolution Chemicals Ltd Process for the production of tibolone
KR100716981B1 (en) * 2004-09-30 2007-05-10 삼성전자주식회사 Method for searching optimal path of mass transportation and mobile apparatus therewith
BRPI1012669A2 (en) * 2009-06-29 2016-04-05 Merz Pharma Gmbh & Co Kgaa method of preparing 3,3,5,5-tetramethylcyclohexanone, method of preparing 1-amino-1,3,3,5,5, pentamethylcyclohexane or a pharmaceutically acceptable salt thereof and compound
CN111944001A (en) * 2020-07-09 2020-11-17 浙江神洲药业有限公司 Preparation method of tibolone

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3341557A (en) * 1961-06-05 1967-09-12 Upjohn Co 7-methyltestosterones
US3470216A (en) * 1966-11-29 1969-09-30 Du Pont Selected 17,17-difluoro unsaturated androstanes
FR2054527B1 (en) * 1969-07-28 1973-06-08 Roussel Uclaf
US3798213A (en) * 1971-01-25 1974-03-19 Merck & Co Inc 7 alpha-methyl-20-spiroxane-3-ones and process
DE2558088C2 (en) * 1975-12-19 1985-05-30 Schering AG, 1000 Berlin und 4709 Bergkamen Process for the preparation of 4-androstene-3,17-dione derivatives
JPS56145239A (en) * 1980-04-11 1981-11-11 Sumitomo Chem Co Ltd Novel bicyclooctane derivative and its preparation
US4298559A (en) * 1980-07-23 1981-11-03 Dow Corning Corporation High yield silicon carbide from alkylated or arylated pre-ceramic polymers
US6548491B2 (en) * 1997-12-24 2003-04-15 Sri International Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
US6054446A (en) * 1997-12-24 2000-04-25 Sri International Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
EP1212345B1 (en) * 1999-04-06 2003-08-06 Akzo Nobel N.V. Orally active 7-alpha-alkyl androgens
TW548277B (en) * 1999-07-16 2003-08-21 Akzo Nobel Nv Orally active androgens
WO2001040255A2 (en) * 1999-12-02 2001-06-07 Akzo Nobel N.V. 14,15-beta-methylene substituted androgens
US6784170B2 (en) * 2000-02-11 2004-08-31 Sri International Synthesis of anti-estrogenic and other therapeutic steroids from 21-hydroxy-19-norpregna-4-en-3-one
IL153934A0 (en) * 2000-07-28 2003-07-31 Akzo Nobel Nv 16 alpha-methyl or ethyl substituted estrogens
US20040010138A1 (en) * 2002-03-21 2004-01-15 Schering Ag Process for the production of 7alpha-methyl steroids
US7304157B2 (en) * 2004-09-28 2007-12-04 Bristol-Myers Squibb Company Efficient synthesis of 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones

Also Published As

Publication number Publication date
US20050090476A1 (en) 2005-04-28
PE20030926A1 (en) 2003-10-29
ATE453659T1 (en) 2010-01-15
PL208163B1 (en) 2011-03-31
CN1863814A (en) 2006-11-15
JP2005519899A (en) 2005-07-07
KR20040077727A (en) 2004-09-06
IL162770A0 (en) 2005-11-20
IL162770A (en) 2011-06-30
MXPA04007049A (en) 2004-10-14
AU2003205604B2 (en) 2009-11-26
ZA200405257B (en) 2005-08-31
JP5250174B2 (en) 2013-07-31
US20100204497A1 (en) 2010-08-12
CA2472379C (en) 2010-05-25
HRP20040634A2 (en) 2004-10-31
KR100937179B1 (en) 2010-01-19
BRPI0306736B8 (en) 2021-05-25
IS2740B (en) 2011-06-15
NZ533970A (en) 2005-10-28
EP1470151B1 (en) 2009-12-30
AU2003205604A1 (en) 2003-07-30
IS7339A (en) 2004-06-28
BRPI0306736B1 (en) 2017-11-07
PL371583A1 (en) 2005-06-27
CN100372864C (en) 2008-03-05
YU63004A (en) 2006-08-17
NO327095B1 (en) 2009-04-20
DE60330749D1 (en) 2010-02-11
RS51490B (en) 2011-04-30
EP1470151A1 (en) 2004-10-27
ECSP045180A (en) 2004-08-27
BR0306736A (en) 2004-12-28
AR038165A1 (en) 2004-12-29
HRP20040634B1 (en) 2013-07-31
RU2004125580A (en) 2006-01-27
TWI322813B (en) 2010-04-01
RO122913B1 (en) 2010-04-30
NO20043455L (en) 2004-08-19
AU2003205604B8 (en) 2009-12-24
ES2336439T3 (en) 2010-04-13
TW200302731A (en) 2003-08-16
RU2305105C2 (en) 2007-08-27
WO2003059931A1 (en) 2003-07-24
CA2472379A1 (en) 2003-07-24

Similar Documents

Publication Publication Date Title
SI1555267T1 (en) 2,3-DIHYDRO-6-NITROIMIDAZOS2,1-bCOXAZOLES
HK1098737A1 (en) Process for the preparation of 1,1,1,3,3-pentafluoro-2-chloropropene and 1,1,1,3,3,3-hexafluoro-2-chloropropane
ZA200203252B (en) Process for preparing 4"-substituted-9-deoxo-9A-AZA-9A-homoerythromycina derivatives.
IL166710A0 (en) Process for the preparation of 4-ÄÄ4-ÄÄ-(2-cyanoethenyl)2,6-dimethylphenylÜaminoÜ-2-pyrimidinylÜaminoÜbenzonitrile
HRP20050328A2 (en) Process for the preparation of (s,s)-cis-2-benzhyd
AU2003265589A8 (en) Process for the preparation of 1,1,1,2,2-pentafluoroethane
HK1086008A1 (en) Process for preparing substituted 5-amino-pyrazolo-Ä4,3-eÜ-1,2,4-triazoloÄ1,5-cÜpyrimidines
IL162059A0 (en) Process for the synthesis of -amino- chirally purealcohols
IL162310A0 (en) 3,4-Dihydro-1h-isoquinoloin-2-yl-derivatives
EG23417A (en) Process for the preparation 7 a-methylsteroids.
PL377292A1 (en) Improved process for the preparation of 1,3-substituted indenes
ZA200509447B (en) 8β-vinyl-11β-(ω-substituted)alkyl-estra-1,3,5(10)-trienes
MXPA03009210A (en) New process for the preparation of oxabispidines.
MXPA03008441A (en) Dgr;1.
ZA200004598B (en) Fortification process.
GB0202011D0 (en) The Fucker
AU2002300045A8 (en) process error - see application no. 50683/02
ZA200205516B (en) Process.
AU2003303760A1 (en) 2,6-dihalogeno-8-substituent-purine compound and process for producing the same
MXPA03005165A (en) New process for the preparation diaryl-4-amino-piperidinyl compounds.
AP2003002772A0 (en) Novel substituted 1, 2, 4-trixanes useful as antimatarial agents and a process for the preparation hereof
AUPS260702A0 (en) Process for the preparation of 2,6-difluoropurines
AU2002241192A8 (en) Process for the preparation of 1-(2,6,6-trimethyl-2-cyclohexene-1-yl)-but-2-ene-1-one
EG23305A (en) Preparation of 1,2-dicloroethane.
SI1549647T1 (en) Substituted c-imidazo,1,2-a pyridin-3-yl-methylamines